Acute Myeloid Leukemia, Version 3.2023

Daniel A. Pollyea; Jessica K. Altman; Rita Assi; Dale Bixby; Amir T. Fathi; James M. Foran; Ivana Gojo; Aric C. Hall; Brian A. Jonas; Ashwin Kishtagari; Jeffrey Lancet; Lori Maness; James Mangan; Gabriel Mannis; Guido Marcucci; Alice Mims; Kelsey Moriarty; Moaath Mustafa Ali; Jadee Neff; Reza Nejati; Rebecca Olin; Mary Elizabeth Percival; Alexander Perl; Amanda Przespolewski; Dinesh Rao; Farhad Ravandi; Rory Shallis; Paul J. Shami; Eytan Stein; Richard M. Stone; Kendra Sweet; Swapna Thota; Geoffrey Uy; Pankit Vachhani; Carly J. Cassara; Deborah A. Freedman-Cass; Katie Stehman

doi:10.6004/jnccn.2023.0025

Acute Myeloid Leukemia, Version 3.2023

Daniel A. Pollyea, Jessica K. Altman, Rita Assi, Dale Bixby, Amir T. Fathi, James M. Foran, Ivana Gojo, Aric C. Hall, Brian A. Jonas, Ashwin Kishtagari, Jeffrey Lancet, Lori Maness, James Mangan, Gabriel Mannis, Guido Marcucci, Alice Mims, Kelsey Moriarty, Moaath Mustafa Ali, Jadee Neff, Reza NejatiRebecca Olin, Mary Elizabeth Percival, Alexander Perl, Amanda Przespolewski, Dinesh Rao, Farhad Ravandi, Rory Shallis, Paul J. Shami, Eytan Stein, Richard M. Stone, Kendra Sweet, Swapna Thota, Geoffrey Uy, Pankit Vachhani, Carly J. Cassara, Deborah A. Freedman-Cass, Katie Stehman

Leukemia

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Abstract

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other tissues. It is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths from leukemias in the United States. Like AML, blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a myeloid malignancy. It is a rare malignancy characterized by the aggressive proliferation of precursors of plasmacytoid dendritic cells that frequently involves the bone marrow, skin, central nervous system, and other organs and tissues. This discussion section focuses on the diagnosis and management of BPDCN as outlined in the NCCN Guidelines for AML.

Original language	English (US)
Pages (from-to)	503-513
Number of pages	11
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	21
Issue number	5
DOIs	https://doi.org/10.6004/jnccn.2023.0025
State	Published - May 2023

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2023.0025

Cite this

Pollyea, D. A., Altman, J. K., Assi, R., Bixby, D., Fathi, A. T., Foran, J. M., Gojo, I., Hall, A. C., Jonas, B. A., Kishtagari, A., Lancet, J., Maness, L., Mangan, J., Mannis, G., Marcucci, G., Mims, A., Moriarty, K., Ali, M. M., Neff, J., ... Stehman, K. (2023). Acute Myeloid Leukemia, Version 3.2023. JNCCN Journal of the National Comprehensive Cancer Network, 21(5), 503-513. https://doi.org/10.6004/jnccn.2023.0025

Pollyea, DA, Altman, JK, Assi, R, Bixby, D, Fathi, AT, Foran, JM, Gojo, I, Hall, AC, Jonas, BA, Kishtagari, A, Lancet, J, Maness, L, Mangan, J, Mannis, G, Marcucci, G, Mims, A, Moriarty, K, Ali, MM, Neff, J, Nejati, R, Olin, R, Percival, ME, Perl, A, Przespolewski, A, Rao, D, Ravandi, F, Shallis, R, Shami, PJ, Stein, E, Stone, RM, Sweet, K, Thota, S, Uy, G, Vachhani, P, Cassara, CJ, Freedman-Cass, DA & Stehman, K 2023, 'Acute Myeloid Leukemia, Version 3.2023', JNCCN Journal of the National Comprehensive Cancer Network, vol. 21, no. 5, pp. 503-513. https://doi.org/10.6004/jnccn.2023.0025

@article{a961df1260494cf9ad33c89157d731cc,

title = "Acute Myeloid Leukemia, Version 3.2023",

abstract = "Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other tissues. It is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths from leukemias in the United States. Like AML, blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a myeloid malignancy. It is a rare malignancy characterized by the aggressive proliferation of precursors of plasmacytoid dendritic cells that frequently involves the bone marrow, skin, central nervous system, and other organs and tissues. This discussion section focuses on the diagnosis and management of BPDCN as outlined in the NCCN Guidelines for AML.",

author = "Pollyea, {Daniel A.} and Altman, {Jessica K.} and Rita Assi and Dale Bixby and Fathi, {Amir T.} and Foran, {James M.} and Ivana Gojo and Hall, {Aric C.} and Jonas, {Brian A.} and Ashwin Kishtagari and Jeffrey Lancet and Lori Maness and James Mangan and Gabriel Mannis and Guido Marcucci and Alice Mims and Kelsey Moriarty and Ali, {Moaath Mustafa} and Jadee Neff and Reza Nejati and Rebecca Olin and Percival, {Mary Elizabeth} and Alexander Perl and Amanda Przespolewski and Dinesh Rao and Farhad Ravandi and Rory Shallis and Shami, {Paul J.} and Eytan Stein and Stone, {Richard M.} and Kendra Sweet and Swapna Thota and Geoffrey Uy and Pankit Vachhani and Cassara, {Carly J.} and Freedman-Cass, {Deborah A.} and Katie Stehman",

year = "2023",

month = may,

doi = "10.6004/jnccn.2023.0025",

language = "English (US)",

volume = "21",

pages = "503--513",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "5",

}

TY - JOUR

T1 - Acute Myeloid Leukemia, Version 3.2023

AU - Pollyea, Daniel A.

AU - Altman, Jessica K.

AU - Assi, Rita

AU - Bixby, Dale

AU - Fathi, Amir T.

AU - Foran, James M.

AU - Gojo, Ivana

AU - Hall, Aric C.

AU - Jonas, Brian A.

AU - Kishtagari, Ashwin

AU - Lancet, Jeffrey

AU - Maness, Lori

AU - Mangan, James

AU - Mannis, Gabriel

AU - Marcucci, Guido

AU - Mims, Alice

AU - Moriarty, Kelsey

AU - Ali, Moaath Mustafa

AU - Neff, Jadee

AU - Nejati, Reza

AU - Olin, Rebecca

AU - Percival, Mary Elizabeth

AU - Perl, Alexander

AU - Przespolewski, Amanda

AU - Rao, Dinesh

AU - Ravandi, Farhad

AU - Shallis, Rory

AU - Shami, Paul J.

AU - Stein, Eytan

AU - Stone, Richard M.

AU - Sweet, Kendra

AU - Thota, Swapna

AU - Uy, Geoffrey

AU - Vachhani, Pankit

AU - Cassara, Carly J.

AU - Freedman-Cass, Deborah A.

AU - Stehman, Katie

PY - 2023/5

Y1 - 2023/5

N2 - Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other tissues. It is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths from leukemias in the United States. Like AML, blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a myeloid malignancy. It is a rare malignancy characterized by the aggressive proliferation of precursors of plasmacytoid dendritic cells that frequently involves the bone marrow, skin, central nervous system, and other organs and tissues. This discussion section focuses on the diagnosis and management of BPDCN as outlined in the NCCN Guidelines for AML.

AB - Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other tissues. It is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths from leukemias in the United States. Like AML, blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a myeloid malignancy. It is a rare malignancy characterized by the aggressive proliferation of precursors of plasmacytoid dendritic cells that frequently involves the bone marrow, skin, central nervous system, and other organs and tissues. This discussion section focuses on the diagnosis and management of BPDCN as outlined in the NCCN Guidelines for AML.

UR - http://www.scopus.com/inward/record.url?scp=85158152265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85158152265&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2023.0025

DO - 10.6004/jnccn.2023.0025

M3 - Article

C2 - 37156478

AN - SCOPUS:85158152265

SN - 1540-1405

VL - 21

SP - 503

EP - 513

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 5

ER -

Acute Myeloid Leukemia, Version 3.2023

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this